Donald School Journal of Ultrasound in Obstetrics and Gynecology

Register      Login

VOLUME 15 , ISSUE 3 ( July-September, 2021 ) > List of Articles

REVIEW ARTICLE

Vasa Previa: Diagnosis and Management

Daisuke Tachibana, Takuya Misugi

Keywords : Diagnosis, Management, Ultrasound, Vasa previa

Citation Information : Tachibana D, Misugi T. Vasa Previa: Diagnosis and Management. Donald School J Ultrasound Obstet Gynecol 2021; 15 (3):301-305.

DOI: 10.5005/jp-journals-10009-1711

License: CC BY-NC 4.0

Published Online: 30-09-2021

Copyright Statement:  Copyright © 2021; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Vasa previa (VP) is a catastrophic condition which, if unrecognized before the rupture of membranes or labor onset, leads to fetal exsanguination due to the laceration of fetal vulnerable blood vessels lacking the protection of Wharton\'s jelly. Recently, obstetricians seem to be more careful in the scanning of umbilical cord insertion because of the increased awareness of VP and the accumulated knowledge of its risk factors, such as velamentous cord insertion, the presence of second-trimester placenta previa, bilobed placenta, and pregnancy by assisted reproductive technology (ART). However, the detection and management of VP is still challenging. In this review, the authors focus on the ultrasound diagnosis and clinical management of VP.


PDF Share
  1. Catanzarite V, Maida C, Thomas W, et al. Prenatal sonographic diagnosis of vasa previa: ultrasound findings and obstetric outcome in ten cases. Ultrasound Obstet Gynecol 2001;18(2):109–115. DOI: 10.1046/j.1469-0705.2001.00448.x.
  2. Oyelese KO, Turner M, Lees C, et al. Vasa previa: an avoidable obstetric tragedy. Obstet Gynecol Surv 1999;54(2):138–145. DOI: 10.1097/00006254-199902000-00024.
  3. Sinkey RG, Odibo AO, Dashe JS. Society of maternal-fetal (SMFM) publications committee, #37: diagnosis and management of vasa previa. Am J Obstet Gynecol 2015;213(5):615–619. DOI: 10.1016/j.ajog.2015.08.031.
  4. Gagnon RJ. No. 231-guidelines for the management of vasa previa. Obstet Gynaecol Can 2017;39(10):e415–e421. DOI: 10.1016/j.jogc.2017.08.016.
  5. Jauniaux E, Alfirevic Z, Bhide AG, et al. Royal College of Obstetricians and Gynaecologists. Vasa praevia: diagnosis and management: green-top guideline no. 27b. BJOG 2019;126(1):e49–e61. DOI: 10.1111/1471-0528.15307.
  6. Hasegawa J, Nakamura M, Ichizuka K, et al. Vasa previa is not infrequent. J Matern Fetal Neonatal Med 2012;25(12):2795–2796. DOI: 10.3109/14767058.2012.712570.
  7. Klahr R, Fox NS, Zafman K, et al. Frequency of spontaneous resolution of vasa previa with advancing gestational age. Am J Obstet Gynecol 2019;221(6):646.e1–646.e7. DOI: 10.1016/j.ajog.2019.06.040.
  8. Oyelese Y, Catanzarite V, Prefumo F, et al. Vasa previa: the impact of prenatal diagnosis on outcomes. Obstet Gynecol 2004;103(5 Pt 1):937–942. DOI: 10.1097/01.AOG.0000123245.48645.98.
  9. Oyelese Y, Smulian JC. Placenta previa, placenta accreta, and vasa previa. Obstet Gynecol 2006;107(4):927–941. DOI: 10.1097/01.AOG.0000207559.15715.98.
  10. Englert Y, Imbert MC, Van Rosendael E, et al. Morphological anomalies in the placentae of IVF pregnancies: preliminary report of a multicentric study. Hum Reprod 1987;2(2):155–157. DOI: 10.1093/oxfordjournals.humrep.a136500.
  11. Jauniaux E, Englert Y, Vanesse M, et al. Pathologic features of placentas from singleton pregnancies obtained by in vitro fertilization and embryo transfer. Obstet Gynecol 1990;76(1):61–64.
  12. Monie IW. Velamentous insertion of the cord in early pregnancy. Am J Obstet Gynecol 1965;93(2):276–281. DOI: 10.1016/0002-9378(65)90670-8.
  13. Torpin R. Classification of human pregnancy based on depth of intrauterine implantation of the ovum. Am J Obstet Gynecol 1953;66(4):791–800. DOI: 10.1016/s0002-9378(16)38556-8.
  14. Derbala Y, Grochal F, Jeanty P. Vasa previa. J Prenat Med 2007;1(1):2–13.
  15. Suekane T, Tachibana D, Pooh RK, et al. Type-3 vasa previa: normal umbilical cord insertion cannot exclude vasa previa in cases with abnormal placental location. Ultrasound Obstet Gynecol 2020;55(4):556–557. DOI: 10.1002/uog.20347.
  16. Catanzarite V, Cousins L, Daneshmand S, et al. Prenatally diagnosed vasa previa: a single-institution series of 96 cases. Obstet Gynecol 2016;128(5):1153–1161. DOI: 10.1097/AOG.0000000000001680.
  17. Swank ML, Garite TJ, Maurel K, et al. Obstetrix collaborative research network. Vasa previa: diagnosis and management. Am J Obstet Gynecol 2016;215(2):223.e1-6. DOI: 10.1016/j.ajog.2016.02.044.
  18. Sullivan EA, Javid N, Duncombe G, et al. Vasa previa diagnosis, clinical practice, and outcomes in australia. Obstet Gynecol 2017;130(3):591–598. DOI: 10.1097/AOG.0000000000002198.
  19. Nakai K, Tachibana D, Tahara M, et al. How to differentiate the fetal velamentous vein from maternal blood flow in cases with vasa previa. Prenat Diagn 2020;40(12):1610–1611. DOI: 10.1002/pd.5771.
  20. Ranzini AC, Oyelese Y. How to screen for vasa previa. Ultrasound Obstet Gynecol 2021;57(5):720–725. DOI: 10.1002/uog.23520.
  21. Hasegawa J, Arakaki T, Ichizuka K, et al. Management of vasa previa during pregnancy. J Perinat Med 2015;43(6):783–784. DOI: 10.1515/jpm-2014-0047.
  22. Fishel Bartal M, Sibai BM, Ilan H, et al. Prenatal diagnosis of vasa previa: outpatient versus inpatient management. Am J Perinatol 2019;36(4):422–427. DOI: 10.1055/s-0038-1669396.
  23. Quintero RA, Kontopoulos EV, Bornick PW, et al. In utero laser treatment of type II vasa previa. J Matern Fetal Neonatal Med 2007;20(12):847–851. DOI: 10.1080/14767050701731605.
  24. Hosseinzadeh P, Shamshirsaz AA, Cass DL, et al. Fetoscopic laser ablation of vasa previa in pregnancy complicated by giant fetal cervical lymphatic malformation. Ultrasound Obstet Gynecol 2015;46(4):507–508. DOI: 10.1002/uog.14796.
  25. Johnston R, Shrivastava VK, Chmait RH. Term vaginal delivery following fetoscopic laser photocoagulation of type II vasa previa. Fetal Diagn Ther 2014;35(1):62–64. DOI: 10.1159/000355600.
  26. Chmait RH, Chavira E, Kontopoulos EV, et al. Third trimester fetoscopic laser ablation of type II vasa previa. J Matern Fetal Neonatal Med 2010;23(5):459–462. DOI: 10.3109/14767050903156718.
  27. Chmait RH, Catanzarite V, Chon AH, et al. Fetoscopic laser ablation therapy for type II vasa previa. Fetal Diagn Ther 2020;47(9):682–688. DOI: 10.1159/000508044.
  28. Rebarber A, Dolin C, Fox NS, et al. Natural history of vasa previa across gestation using a screening protocol. J Ultrasound Med 2014;33(1):141–147. DOI: 10.7863/ultra.33.1.141.
  29. Erfani H, Haeri S, Shainker SA, et al. Vasa previa: a multicenter retrospective cohort study. Am J Obstet Gynecol 2019;221(6):644.e1–644.e5. DOI: 10.1016/j.ajog.2019.06.006.
  30. Lee W, Lee VL, Kirk JS, et al. Vasa previa: prenatal diagnosis, natural evolution, and clinical outcome. Obstet Gynecol 2000;95(4):572–576. DOI: 10.1097/00006250-200004000-00018.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.